Advances in CAR T Therapy for Hematologic Malignancies. Pharmacotherapy. 2020..
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia. N Engl J Med. 2014;371(16):1507-1517.
Clinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transpl. Biol Blood Marrow Transplant. 2018.
Early donor chimerism levels predict relapse and survival after allogeneic stem-cell transplantation with reduced intensity conditioning. Biol Blood Marrow Transplant. 2014.
Immunotherapy with cells (article not eligible for CME credit). Hematology Am Soc Hematol Educ Program. 2020;2020(1):590-597..
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. Clin Lymphoma Myeloma Leuk. 2015.
The Promise of Chimeric Antigen Receptor T-Cell Therapy. Oncology (Williston Park). 2016;30(10)..